GenSight Biologics

Paris-based GenSight Biologics is a privately owned biopharmaceutical company, dedicated to the development and commercialization of gene therapy based treatments of retinal degenerative diseases. Based on recent results obtained by the teams of its scientific founders, the company develops innovative approaches to (i) prevent retinal degeneration in selected pathological conditions and (ii) to restore vision in patients suffering from very low vision or blindness.
Company Growth (employees)
Type
Private
HQ
Paris, FR
Founded
2011
Size (employees)
31 (est)
GenSight Biologics was founded in 2011 and is headquartered in Paris, FR

GenSight Biologics Office Locations

GenSight Biologics has an office in Paris
Paris, FR (HQ)
74 Rue Du Faubourg Saint Antoine

GenSight Biologics Data and Metrics

Summary Metrics

Founding Date

2011

Total Funding

$77.7 m

Latest funding size

$36 m

Time since last funding

almost 2 years

Investors

GenSight Biologics's latest funding round in July 2015 was reported to be $36 m. In total, GenSight Biologics has raised $77.7 m

GenSight Biologics News and Updates

GenSight Biologics Company Life and Culture

You may also be interested in